


Ask a doctor about a prescription for METASEDIN 10 mg/ml INJECTABLE SOLUTION
Package Leaflet: Information for the User
Metasedin 10 mg/ml injectable solution
Metadone hydrochloride
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the pack
Metasedin 10 mg/ml injectable solution is a medicine that contains a substance called metadone, which belongs to the group of narcotic analgesic drugs. Metadone is a central analgesic with a potency slightly higher than that of morphine. It also produces less euphoria and a similar withdrawal syndrome, although more prolonged.
Metasedin 10 mg/ml injectable solution is indicated for intense pain of any etiology. Post-operative, post-traumatic, neoplastic, neuritic, burn-related pain, whenever they do not respond to minor analgesics. Treatment of narcotic withdrawal syndrome.
Do not use Metasedin:
Warnings and precautions
Talk to your doctor or pharmacist if you have any of the following symptoms before starting or while using Metasedin:
Tolerance, dependence, and addiction
This medicine contains an opioid medicine called metadone. Repeated use of opioids can reduce the effectiveness of the medicine (your body gets used to the medicine, this is known as tolerance). Repeated use of Metasedin can also cause dependence, abuse, and addiction, which can lead to a potentially fatal overdose.
The risk of side effects may increase with a higher dose and longer duration of use.
Dependence or addiction can make you feel like you no longer have control over the amount of medicine you need to take or how often you need to take it. When used to treat pain, you may feel like you need to keep taking the medicine, even when it no longer helps to relieve your pain.
The risk of becoming dependent or addicted varies from person to person. You may be at higher risk of becoming dependent or addicted to Metasedin if:
If you notice any of the following signs while taking Metasedin, it could be a sign that you have become dependent or addicted.
If you notice any of these signs, talk to your doctor to address the most appropriate therapeutic strategy in your case, including when it is appropriate to stop taking it and how to do so safely (see section 3 "If you stop treatment with Metasedin").
Respiratory disorders related to sleep
Metasedin can cause sleep-related respiratory disorders, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, nighttime awakenings due to lack of breath, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else notices these symptoms, contact your doctor. Your doctor may consider reducing the dose.
Use in athletes
This medicine contains a component that can produce a positive result in doping tests.
Children and adolescents
Metasedin is not recommended for use in children and adolescents under 18 years of age, due to the lack of safety and efficacy data in this population. Additionally, children are more sensitive to the effects of metadone than adults.
Other medicines and Metasedin
There are some medicines that can affect the proper functioning of Metasedin or Metasedin itself can reduce the effectiveness of other medicines that are being taken at the same time. These drug interactions can increase or decrease the effect of one of the two medicines and may increase the risk or severity of side effects.
Do not take Metasedin if you are taking monoamine oxidase inhibitors (MAOIs) or if you have taken an MAOI in the last two weeks.
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine, such as:
Using Metasedin with food, drinks, and alcohol
Alcohol can increase the side effects of metadone, so it should not be taken during treatment with this medicine.
Grapefruit juice may modify the effect of metadone, so it should not be taken with Metasedin.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
If Metasedin is used during pregnancy, your baby may suffer from withdrawal syndrome. Be careful if you are taking a pregnancy test, as metadone can interfere with the results.
Metasedin should not be used if you are in labor.
Breastfeeding
Metadone is excreted in breast milk. It will only be administered to breastfeeding mothers when the benefits to the infant outweigh the possible risks. Breastfeeding in these conditions could prevent the appearance of a withdrawal syndrome in the newborn.
Talk to your doctor if you are breastfeeding or planning to breastfeed while taking metadone, as it may affect your baby. Monitor your baby for any abnormal signs or symptoms, such as increased sleepiness (more than usual), difficulty breathing, or weakness. Contact your doctor immediately if you notice any of these symptoms.
Driving and using machines
Metasedin can cause drowsiness, dizziness, or other symptoms that can affect your ability to drive or operate machines. If you notice any of these effects, avoid driving vehicles or using machines.
Metasedin contains sodium
This medicine contains less than 23 mg (1 mmol) of sodium per ampoule, so it is considered "essentially sodium-free".
Before starting treatment and periodically during treatment, your doctor will talk to you about what you can expect from using Metasedin, when and for how long you should take it, when to contact your doctor, and when to stop taking it (see also "If you stop treatment with Metasedin").
Metasedin should only be administered by qualified healthcare personnel with adequate knowledge of its use. The administration of the product and the handling of the needles should be done with caution.
The dosage must be individualized, so your doctor will establish the appropriate dose for you and make any necessary adjustments.
If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.
Use in adults:
From 1/2 to 1 ampoule per dose, subcutaneously, according to the intensity of the pain. This dose may be repeated according to the doctor's criteria.
Remember to use your medicine.
Your doctor will indicate the duration of treatment with Metasedin.
If you receive more Metasedin than you should
Your doctor will ensure that you receive the correct dose for your condition. In case of overdose, you may experience more side effects. If you think you have received too much Metasedin, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you take too much metadone, you may experience:
In case of extreme intoxication, respiratory arrest, circulatory collapse, heart failure, and death may occur.
If you forget to use Metasedin
Do not use a double dose to make up for forgotten doses.
If you stop treatment with Metasedin
Sudden interruption of treatment, in patients with physical dependence, can precipitate a withdrawal syndrome.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
In general, methadone causes adverse effects similar to those of morphine.
The most serious adverse effects of methadone, as with other opioids, are respiratory depression (difficulty breathing) and, to a lesser extent, a decrease in blood pressure, with cases of respiratory arrest, shock, and cardiac arrest having occurred. The most frequent adverse effects are dizziness, sedation, nausea, vomiting, and excessive sweating. These effects seem to be more intense in outpatient patients and in those who do not have intense chronic pain. In such patients, the use of lower doses is recommended.
Some adverse effects can be alleviated if the patient lies down.
Tell your doctor immediately if you experience:
Other possible adverse effects may be the following:
Very Common (may affect more than 1 in 10 patients)
nausea, vomiting.
Common (may affect up to 1 in 10 patients)
excessive sweating
fatigue, somnolence, sedation
weight gain
fluid retention
constipation
rash, which may appear and disappear
blurred vision, small pupils, dry eyes
dizziness, vertigo
changes in mood, feeling overly excited (euphoria) or seeing or hearing things that are not real (hallucinations)
Uncommon (may affect up to 1 in 100 patients)
difficulty breathing (respiratory depression), especially with high doses
worsening of asthma
low blood pressure
headache, syncope, or sudden loss of consciousness
feeling discouraged (dysphoria), agitation, confusion, disorientation, difficulty sleeping
you may become dependent on Metasedin, for more information, see section 2 "Warnings and Precautions"
itching, skin rashes, hives
dry mouth or nose, tongue inflammation, facial redness
difficulty urinating (urinary retention), pain in the lower back and abdomen caused by muscle spasms
alteration of bile duct movement (may manifest as nausea, vomiting, or both, biliary pain in the upper right abdomen or radiating to the right shoulder region)
low body temperature (hypothermia)
feeling of weakness, fatigue
decreased sexual desire or difficulty achieving or maintaining an erection
painful menstrual period, absence of menstruation
secretion of milk from the nipple (galactorrhea)
increased fluid in the lung (pulmonary edema)
Rare (may affect up to 1 in 1000 patients)
alterations in heart rhythm (both rapid and skipped beats)
abnormality in the electrocardiogram (ECG), known as prolongation of the QT interval, which may cause a heart rhythm disorder called "torsade de pointes" (especially with high doses of methadone)
cardiac arrest
shock
respiratory arrest
Other adverse effects reported, with unknown frequency, are
loss of appetite
bloating, swollen legs (this may be a sign that your body is retaining more water than normal)
increased intracranial pressure (especially with high doses)
involuntary, rapid, and repetitive eye movements, strabismus
reduced visual acuity
sleep apnea (pauses in breathing during sleep)
reduction in blood platelets, which increases the risk of bleeding or bruising in patients with chronic hepatitis
low levels of potassium and magnesium
decreased production of adrenal and sex hormones
low blood sugar levels
high levels of prolactin in the blood
If you observe any other reaction not described in this prospectus, consult your doctor or pharmacist.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report it directly through the Spanish Pharmacovigilance System for Human Use Medicines, Website: www.notificaRAM.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Store this medicine in a safe and protected place, where other people cannot access it. It can cause serious harm and be fatal to people who have not been prescribed it.
Do not store at a temperature above 25°C.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Metasedin
Appearance of the Product and Package Contents
Metasedin 10 mg/ml injectable solution is a colorless and transparent solution, and it is presented in packages of 12 ampoules.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Esteve Pharmaceuticals, S.A.
Passeig de la Zona Franca, 109
08038 Barcelona
Spain
Manufacturer
Ronda de los Olivares, parcela 11
Polígono Industrial Los Olivares
23009 Jaén
Spain
Towa Pharmaceutical Europe, S.L.
c/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Date of the Last Revision of this Prospectus: March 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of METASEDIN 10 mg/ml INJECTABLE SOLUTION in November, 2025 is around 5.51 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for METASEDIN 10 mg/ml INJECTABLE SOLUTION – subject to medical assessment and local rules.